Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors
- 1 January 1982
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 2 (6) , 407-410
- https://doi.org/10.3109/02713688209000786
Abstract
The effect of aldose reductase inhibitors such as sorbinil, alrestatin and quercitrin was studied on the aldose reductase purified from human brain and lens, and aldehyde reductase I purified from human liver, and aldehyde reductase II purified from human brain, liver and red cells. None of the aldose reductase inhibitors were specific for aldose reductase. Fifty micromolar Sorbinil [50 .mu.M), besides inhibiting aldose reductase, completely inhibits aldehyde reductase II from the brain, liver and red cells. Alrestatin and quercitrin also are potent inhibitors of aldehyde reductase I and aldehyde reductase II.This publication has 17 references indexed in Scilit:
- Purification and properties of human liver aldehyde reductasesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982
- Kinetics of an orally absorbed aldose reductase inhibitor, sorbinilClinical Pharmacology & Therapeutics, 1981
- Aldose reductase inhibition: Studies with alrestatinMetabolism, 1979
- CP-45,634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic ratsMetabolism, 1979
- Diabetic Cataracts and FlavonoidsScience, 1977
- Flavonoids as Inhibitors of Lens Aldose ReductaseScience, 1975
- Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase InhibitorScience, 1973
- The Sorbitol Pathway and the Complications of DiabetesNew England Journal of Medicine, 1973
- Role of Sorbitol Pathway in NeuropathyPublished by Elsevier ,1973
- Formation of Polyols by the Lens of the Rat with ‘Sugar’ CataractNature, 1959